| Mortality in sickle cell disease--life expectancy and risk factors for early death OS Platt, DJ Brambilla, WF Rosse, PF Milner, O Castro, MH Steinberg, ... New England Journal of Medicine 330 (23), 1639-1644, 1994 | 4215 | 1994 |
| CRISPR-Cas9 gene editing for sickle cell disease and β-thalassemia H Frangoul, D Altshuler, MD Cappellini, YS Chen, J Domm, BK Eustace, ... New England Journal of Medicine 384 (3), 252-260, 2021 | 1669 | 2021 |
| Sickle cell disease FB Piel, MH Steinberg, DC Rees New England Journal of Medicine 376 (16), 1561-1573, 2017 | 1549 | 2017 |
| Disorders of hemoglobin: genetics, pathophysiology, and clinical management MH Steinberg, BG Forget, DR Higgs, DJ Weatherall Cambridge University Press, 2009 | 1278* | 2009 |
| Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment MH Steinberg, F Barton, O Castro, CH Pegelow, SK Ballas, A Kutlar, ... Jama 289 (13), 1645-1651, 2003 | 1222 | 2003 |
| Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes GJ Kato, MT Gladwin, MH Steinberg Blood reviews 21 (1), 37-47, 2007 | 1030 | 2007 |
| Management of sickle cell disease MH Steinberg New England Journal of Medicine 340 (13), 1021-1030, 1999 | 909 | 1999 |
| Intravascular hemolysis and the pathophysiology of sickle cell disease GJ Kato, MH Steinberg, MT Gladwin The Journal of clinical investigation 127 (3), 750-760, 2017 | 734 | 2017 |
| Erythrocyte adherence to endothelium in sickle-cell anemia: a possible determinant of disease severity RP Hebbel, MAB Boogaerts, JW Eaton, MH Steinberg New England Journal of Medicine 302 (18), 992-995, 1980 | 690 | 1980 |
| Fetal hemoglobin in sickle cell anemia I Akinsheye, A Alsultan, N Solovieff, D Ngo, CT Baldwin, P Sebastiani, ... Blood, The Journal of the American Society of Hematology 118 (1), 19-27, 2011 | 677 | 2011 |
| Genetic signatures of exceptional longevity in humans P Sebastiani, N Solovieff, AT DeWan, KM Walsh, A Puca, SW Hartley, ... PloS one 7 (1), e29848, 2012 | 602 | 2012 |
| The risks and benefits of long‐term use of hydroxyurea in sickle cell anemia: a 17.5 year follow‐up MH Steinberg, WF McCarthy, O Castro, SK Ballas, FD Armstrong, W Smith, ... American journal of hematology 85 (6), 403-408, 2010 | 589 | 2010 |
| Spontaneous oxygen radical generation by sickle erythrocytes. RP Hebbel, JW Eaton, M Balasingam, MH Steinberg The Journal of clinical investigation 70 (6), 1253-1259, 1982 | 583 | 1982 |
| Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms M Saleh, JP Vaillancourt, RK Graham, M Huyck, SM Srinivasula, ... Nature 429 (6987), 75-79, 2004 | 537 | 2004 |
| Hydroxyurea and sickle cell anemia clinical utility of a myelosuppressive “Switching” agent S Charache, FB Barton, RD Moore, ML Terrin, MH Steinberg, GJ Dover, ... Medicine 75 (6), 300-326, 1996 | 466 | 1996 |
| Predicting clinical severity in sickle cell anaemia MH Steinberg British journal of haematology 129 (4), 465-481, 2005 | 455 | 2005 |
| Fetal hemoglobin in sickle cell anemia: determinants of response to hydroxyurea MH Steinberg, ZH Lu, FB Barton, ML Terrin, S Charache, GJ Dover, ... Blood, The Journal of the American Society of Hematology 89 (3), 1078-1088, 1997 | 439 | 1997 |
| Vasculopathy in sickle cell disease: biology, pathophysiology, genetics, translational medicine and new research directions GJ Kato, RP Hebbel, MH Steinberg, MT Gladwin American journal of hematology 84 (9), 618, 2009 | 411 | 2009 |
| Genetic dissection and prognostic modeling of overt stroke in sickle cell anemia P Sebastiani, MF Ramoni, V Nolan, CT Baldwin, MH Steinberg Nature genetics 37 (4), 435-440, 2005 | 397 | 2005 |
| Sickle cell anemia, the first molecular disease: overview of molecular etiology, pathophysiology, and therapeutic approaches MH Steinberg The Scientific World Journal 8 (1), 1295-1324, 2008 | 393 | 2008 |
Paola SebastianiTufts Medical CenterEmail yang diverifikasi di tuftsmedicalcenter.org